| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 1950 |
| 1 | PREDNISONE | 1828 |
| 2 | METHOTREXATE SODIUM | 1687 |
| 3 | METHOTREXATE | 1598 |
| 4 | DICLOFENAC SODIUM | 1539 |
| 5 | ACETAMINOPHEN | 1515 |
| 6 | RITUXIMAB | 1501 |
| 7 | DICLOFENAC | 1498 |
| 8 | FOLIC ACID | 1491 |
| 9 | ETANERCEPT | 1490 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRICLOSAN | 100 | 0.1733 |
| 1 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 95 | 0.1444 |
| 2 | CAFFEINE CITRATE | 333 | 0.1427 |
| 3 | DICLOFENAC POTASSIUM TABLETS | 1027 | 0.1185 |
| 4 | NEOMYCIN OINTMENT | 289 | 0.1179 |
| 5 | HYDROCORTISONE BUTYRATE | 217 | 0.1098 |
| 6 | GOLIMUMAB | 1209 | 0.0960 |
| 7 | DICLOFENAC POTASSIUM | 1029 | 0.0931 |
| 8 | CORTISONE ACETATE | 1047 | 0.0838 |
| 9 | PSEUDOEPHEDRINE HCL | 832 | 0.0760 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 2443 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2141 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 2036 |
| 3 | Vitamin C [EPC] | 1659 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 1596 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 1561 |
| 6 | Vitamin B12 [EPC] | 1558 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 1555 |
| 8 | Vitamin D [EPC] | 1520 |
| 9 | Interleukin-17A Antagonist [EPC] | 1419 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 168 | 0.2442 |
| 1 | Endoglycosidase [EPC] | 265 | 0.1430 |
| 2 | Provitamin D2 Compound [EPC] | 1325 | 0.0445 |
| 3 | Interleukin-17A Antagonist [EPC] | 1419 | 0.0381 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 297 | 0.0341 |
| 5 | Aminosalicylate [EPC] | 1403 | 0.0139 |
| 6 | Methylxanthine [EPC] | 806 | 0.0139 |
| 7 | Antirheumatic Agent [EPC] | 1398 | 0.0132 |
| 8 | Tetracycline-class Drug [EPC] | 923 | 0.0130 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 1555 | 0.0112 |